SCHEMBL13638541

SCHEMBL13638541

Cc1nc2cc(NCCN)ccc2c(=O)n1-c1ccc(NC(=O)NS(=O)(=O)c2ccc(Cl)s2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY12 Q9H244 3/20 0.56
NOD1 Q9Y239 1/20 0.41
TP53 P04637 3/20 0.41
PPARG P37231 3/20 0.39
FBP1 P09467 1/20 0.37
MAPT P10636 4/20 0.36
LMNA P02545 2/20 0.36
HDAC3 O15379 1/20 0.36
APP P05067 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC9 Q9UKV0 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36
KDR P35968 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9922948 0.93 P2RY12 (0.54) P2RY12NOD1TP53PPARGFBP1
SCHEMBL9922362 0.91 P2RY12 (0.54) P2RY12NOD1TP53PPARGFBP1
SCHEMBL12161443 0.91 P2RY12 (0.52) P2RY12NOD1TP53PPARGFBP1
SCHEMBL12161436 0.90 P2RY12 (0.53) P2RY12NOD1TP53PPARGFBP1
SCHEMBL12161445 0.89 P2RY12 (0.51) P2RY12NOD1TP53PPARG
SCHEMBL9922949 0.89 P2RY12 (0.51) P2RY12NOD1TP53PPARG
SCHEMBL9922941 0.89 P2RY12 (0.60) P2RY12NOD1TP53PPARGFBP1
SCHEMBL9922938 0.88 P2RY12 (0.57) P2RY12NOD1TP53PPARGFBP1
SCHEMBL9922577 0.88 P2RY12 (0.51) P2RY12NOD1TP53PPARGFBP1
SCHEMBL9922952 0.88 P2RY12 (0.49) P2RY12NOD1TP53PPARGMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622474-B2 Asulfonyl(urea, thiourea, guanidine, cyanoguanidine) compounds; cardiovascular disorders; thrombosis PORTOLA PHARMACEUTICALS, INC. (US) 2009-11-24 US disclosed